Diabetes Research and Clinical Practice
Volume 76, Issue 2 , Pages 187-192, May 2007

Taurine in women with a history of gestational diabetes

  • Giuseppe Seghieri

      Affiliations

    • Department of Internal Medicine, Spedali Riuniti, Viale Matteotti 19, 51100 Pistoia, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 0573352325; fax: +39 0573352005.
  • ,
  • Federica Tesi

      Affiliations

    • Department of Internal Medicine, Spedali Riuniti, Viale Matteotti 19, 51100 Pistoia, Italy
  • ,
  • Loria Bianchi

      Affiliations

    • Department of Internal Medicine, Spedali Riuniti, Viale Matteotti 19, 51100 Pistoia, Italy
  • ,
  • Alberto Loizzo

      Affiliations

    • Istituto Superiore di Sanità, Roma, Italy
  • ,
  • Giuseppe Saccomanni

      Affiliations

    • Department of Pharmaceutical Sciences, University of Pisa, Italy
  • ,
  • Giovanni Ghirlanda

      Affiliations

    • Department of Internal and Geriatric Medicine, Catholic University, Roma, Italy
  • ,
  • Roberto Anichini

      Affiliations

    • Department of Internal Medicine, Spedali Riuniti, Viale Matteotti 19, 51100 Pistoia, Italy
  • ,
  • Flavia Franconi

      Affiliations

    • Center for Biotechnology Development and Biodiversity Research and Department of Pharmacology, University of Sassari, Italy

Received 16 August 2006; accepted 21 August 2006. published online 21 September 2006.

Abstract 

Taurine is the most abundant amino acid in the human body and seems to play an important role in increasing glucose-mediated insulin secretion, as well as in programming β-cell maturation during the prenatal life in utero. To test the hypothesis that plasma taurine is related to glucose tolerance, insulin sensitivity and insulin secretion in subjects with history of β-cell dysfunction such as women with history of gestational diabetes (GDM), we studied 72 non-diabetic women with history of GDM (n=43), impaired glucose tolerance (IGT; n=7), and normal glucose tolerance (NGT; n=22) as previously classified by a 100g-3h-OGTT performed between the 24th and the 28th gestational week. Insulin sensitivity (ISIogtt, calculated through Matsuda–DeFronzo index) and a proxy for insulin secretion (basal plasma C-peptide/fasting plasma glucose; CP/glucose) were measured during and after pregnancy. Plasma taurine was measured after a median period of 6 years (2–11 years) from index pregnancy, when glucose tolerance was retested by a 75g-2h-OGTT. Plasma taurine was significantly lower in women who had experienced GDM and was unrelated to ISIogtt. Moreover, plasma taurine was inversely related to previous gestational area-under-curve of glucose and directly related to post-gestational CP/glucose, as well to CP/glucose measured during pregnancy (p<0.05 for both). The relative risk of altered glucose metabolism during previous pregnancies (IGT+GDM) was higher as plasma taurine decreased, even after adjusting for age, time-lag from pregnancy, body mass index and family history of diabetes (OR: 0.980; CI 95%: 0.963–0.999, p=0.003). In conclusion plasma taurine seems to be a fair marker of altered glucose metabolism during past pregnancies in women with antecedent GDM and appears to be inversely related to the previous as well as to the actual insulin secretion in these subjects.

Keywords: Gestational diabetes, Plasma taurine, Insulin secretion, Post-pregnancy follow-up

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0168-8227(06)00372-X

doi:10.1016/j.diabres.2006.08.008

Diabetes Research and Clinical Practice
Volume 76, Issue 2 , Pages 187-192, May 2007